Endofluke 100 mg/ml Oral Suspension

Ülke: Birleşik Krallık

Dil: İngilizce

Kaynak: VMD (Veterinary Medicines Directorate)

Aktif bileşen:

Triclabendazole

Mevcut itibaren:

Cross Vetpharm Group Ltd

ATC kodu:

QP52ACO1

INN (International Adı):

Triclabendazole

Farmasötik formu:

Oral suspension

Reçete türü:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Terapötik grubu:

Cattle, Sheep

Terapötik alanı:

Anthelmintic flukicide

Yetkilendirme durumu:

Authorized

Yetkilendirme tarihi:

2003-02-20

Ürün özellikleri

Revised: August 2017
AN: 00085/2017
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Endofluke 100 mg/ml Oral Suspension
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE: per ml
Triclabendazole 100mg
EXCIPIENTS:
Methyl Parahydroxybenzoate (E218)
2mg (preservative)
Propyl Parahydroxybenzoate (E216)
0.2mg (preservative)
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral Suspension.
A white to off-white suspension.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle & Sheep
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of adult, immature and early immature stages of
liver fluke (_Fasciola _
_hepatica_) susceptible to triclabendazole.
4.3
CONTRAINDICATIONS
Do not use in animals known to be hypersensitive to the active
substance .
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices, because they
increase the risk of
development of resistance and could ultimately result in ineffective
therapy:
- Too frequent and repeated use of anthelmintics from the same class,
over an
extended period of time.
- Under dosing, which may be due to underestimation of bodyweight,
misadministration of the product or lack of calibration of the dosing
device (if any).
Suspected clinical cases of resistance to anthelmintics should be
further investigated
using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where
the results of
Page 1 of 6
Revised: August 2017
AN: 00085/2017
the test(s) strongly suggest resistance to a particular anthelmintic,
an anthelmintic
belonging to another pharmacological class and having a different mode
of action
should be used.
Resistance to triclabendazole has been reported in _Fasciola hepatica_
in cattle and
sheep. Therefore, the use of this product should be based on local
(regional/farm)
epidemiological information about susceptibility of the _Fasciola
hepatica_ and
recommendations on how to limit further selection for resistance to
anthelmintics.
4.5
SPECIAL PRE